Status:
COMPLETED
Study of Antidepressants in Parkinson's Disease
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Parkinson Disease
Depression
Eligibility:
All Genders
30+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to find out if two antidepressant medications, paroxetine and venlafaxine, can help control depression in Parkinson's disease, and if these medications affect the motor sy...
Detailed Description
Nearly 50 percent of individuals with Parkinson's disease (PD) suffer from depression-a condition that causes disability and can reduce quality of life. The University of Rochester Medical Center is c...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- To be eligible you must be:
- 30 years old or older
- diagnosed with Parkinson's disease
- experiencing symptoms of depression such as sadness, decreased energy, or problems sleeping
Exclusion
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT00086190
Start Date
June 1 2005
End Date
November 1 2009
Last Update
January 4 2013
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94143
2
University of Florida
Gainesville, Florida, United States, 32610
3
University of Miami
Miami, Florida, United States, 33136
4
Emory University School of Medicine
Atlanta, Georgia, United States, 30322